![]() ![]() ![]() If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. We suggest that you always verify the information obtained from linked websites before acting upon this information.Īlso, please be aware that the security and privacy policies on these sites may be different than policies, so please read third party privacy and security policies closely. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We are not an agent for these third parties nor do we endorse or guarantee their products. is not responsible for the content of linked third party websites. Tag: 4d Pharma PLC 4d Pharma PLC (AIM:DDDD) Cancellation of admission to trading on AIM 4d Pharma PLC (AIM:DDDD) Updated Results from Renal Cell Carcinoma. These sites are not under the control of. When you click on these links you will leave the website and will be redirected to another site. Defining the microbiome space is 4D pharma and its pioneering live biotherapeutic products (LBPs), an emerging class of medicines based on single strains of commensal bacteria. ![]() The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. James Richard Clark and David John Pike are authorised to act as insolvency. offers links to other third party websites that may be of interest to our website visitors. Name: 4D pharma plc Ticker: FRPR.F Exchange: OTCPK Founded: 2014 Industry: Biotechnology Sector: Pharmaceuticals & Biotech Implied Market Cap. Supporting documentation for your claim includes invoices, statements of account, proofs of delivery, contracts or any other relevant information. 4D Pharma develops treatments that consist of live bacterial strains taken from fecal samples of healthy donors. We are not responsible for the content or availability of linked sites. Acquiring 4D Pharma Len, S.L.U., 4D Pharma’s Spanish subsidiary, will provide Bacthera with relevant. Disclaimer: You are now leaving website and are going to a website that is not operated by us. Basel, Switzerland, and Hrsholm, Denmark, March 13th 2023 Bacthera, a specialized contract development and manufacturing organization (CDMO), announced today that it has acquired a cGMP manufacturing site in Len (ES) from 4D Pharma. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |